OTRK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ontrak, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

PR Newswire

NEW YORK, March 5, 2021 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ontrak, Inc. (“Ontrak” or the “Company”) (NASDAQ: OTRK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ontrak securities between November 5, 2020 and February 26, 2021, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/otrk.        

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/otrk or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Ontrak you have until May 3, 2021 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/otrk-shareholder-alert-bronstein-gewirtz–grossman-llc-notifies-ontrak-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-301241229.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tricida, Inc. (TCDA)

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tricida, Inc. (TCDA)

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz reminds investors of the upcoming March 8, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tricida, Inc. (“Tricida” or the “Company”) (NASDAQ: TCDA) securities between September 4, 2019 and October 28, 2020,inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

Tricida’s drug candidate, veverimer, is a polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (“CKD”). The Company has completed a Phase 3, double-blind, placebo-controlled trial of veverimer in patients with CKD and metabolic acidosis.

On September 4, 2019, Tricida announced that it had submitted a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) under the Accelerated Approval Program for approval of veverimer for the treatment of metabolic acidosis in patients with CKD.

On July 15, 2020, Tricida announced that it had received a notice from the FDA “identif[ying] deficiencies that preclude discussion of labeling and postmarketing requirements/commitments at this time.” The Company stated that “[t]he notification does not specify the deficiencies identified by the FDA.”

On this news, the Company’s stock price fell $10.56, or 40.31%, to close at $15.64 per share on July 16, 2020, thereby injuring investors.

Then, on October 29, 2020, following its End-of-Review Type A meeting with the FDA, Tricida announced that it “now believes the FDA will also require evidence of veverimer’s effect on CKD progression from a near-term interim analysis of the VALOR-CKD trial for approval under the Accelerated Approval Program and that the FDA is unlikely to rely solely on serum bicarbonate data for determination of efficacy.” Tricida also disclosed that it was “significantly reducing its headcount from 152 to 59 people and will discuss its commitments with vendors and contract service providers to potentially provide additional financial flexibility.”

On this news, the Company’s stock price fell $3.90, or 47.16%, to close at $4.37 per share on October 29, 2020, thereby injuring investors.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Tricida’s NDA for veverimer was materially deficient; (2) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired Tricida securities during the Class Period, you may move the Court no later than March 8, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

[email protected]

www.frankcruzlaw.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

Viper Networks Submits Updated Financials to OTC Markets and Expects to Announce New Partnerships, Projects and Projected Revenues soon

TROY, Mich., March 05, 2021 (GLOBE NEWSWIRE) — Viper Networks, Inc. (OTC Pink: VPER), (Company), an international leader in the LED lighting products and integrated systems markets for Smart City projects, is pleased to announce that the Company has submitted all required financials to OTC Markets for their 2019 and 2020 fiscal years, respectively, ending December 31st.

Additionally, the Viper Networks’ website has been updated and the Company expects to continue with further updates shortly featuring new products and functions; as the Company seeks to become fully compliant with the OTC Markets’ Guidelines for Providing Adequate Current Information.

The Company is also pleased to announce that a successful introduction was provided to the Community Advisory Board (CAG) and to the Porter Ranch neighborhood counsel safety committee this week. By the end of April or earlier, the Company will present their final Smart Air Quality monitoring system design to Los Angeles County officials.

The Company’s smart air quality monitoring system will be serving the community of Porter Ranch to monitor methane gas levels from the Aliso Canyon Gas Facility as a part of a $25 million health study for Los Angeles County.

And finally, shortly after the Company has officially gained ‘Current Status’ with OTC Markets, Viper Networks will commence the start of myriad announcements highlighting all corporate activities, including new partnerships and joint ventures (JV) and all current and upcoming projects and the projected revenues.

Viper Networks CEO, Mr. Shouekani, commented: “Although our financial numbers over the last two years are quite limited. The anticipated or projected revenues for 2021, especially the third and fourth quarters; are as different as night and day. We are certainly living in exciting times and VPER shareholders should know that their Company is striving to be a global leader in positive change.”

For more information go to www.ViperNetworks.com or follow [email protected]

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the U.S. Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this release which are not historical are forward-looking and include any statements regarding beliefs, expectations or intentions regarding the future.
Investor Relations/Media Contact: Scott Gibson, 407.444.5959



AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aquestive securities between December 2, 2019 and September 25, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/aqst.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA’s approval prospects; (3) as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/aqst or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aquestive you have until April 30, 2021 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]



QS, TCDA & GTT Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Shareholders to Contact the Firm

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. 

QuantumScape Corporation
(
NYSE: QS
)

Class Period: November 27, 2020 – December 31, 2020
Deadline: March 8, 2021
For more info:www.bgandg.com/qs
The complaint alleges that throughout the class period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Tricida, Inc.
(NASDAQ: TCDA)

Class Period: September 4, 2019 – October 28, 2020
Deadline: March 8, 2021
For more info:www.bgandg.com/tcda
The complaint alleges that throughout the class period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Tricida’s NDA for veverimer was materially deficient; (2) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

GTT Communications, Inc.
(NYSE: GTT)

Class Period: May 5, 2016 – November 9, 2020
Deadline: March 15, 2021
For more info:www.bgandg.com/gtt
The complaint alleges that throughout the class period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s internal controls suffered from issues related to the recording and reporting of Cost of Telecommunications Services; (2) the Company’s previously reported Cost of Telecommunications was inaccurate or accounted for unsupported adjustments; (3) inadequate internal controls would result in delays in the Company’s 10-Q quarterly reports; and (4) as a result of the foregoing, Defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]



MGI Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies MoneyGram International, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against MoneyGram International, Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired MoneyGram securities between June 17, 2019 and February 22, 2021, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/mgi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that:  (1) XRP, the cryptocurrency that MoneyGram was utilizing as part of its Ripple partnership, was viewed as an unregistered and therefore unlawful security by the SEC; (2) in the event that the SEC decided to enforce the securities laws against Ripple, MoneyGram would be likely to lose the lucrative stream of market development fees that was critical to its financial results throughout the Class Period; and (3) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/mgi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in MoneyGram you have until April 30, 2021 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]



Alphamin Announces Q4 2020 Results / Achieves Record Fourth Quarter EBITDA and Production

GRAND BAIE, Mauritius, March 05, 2021 (GLOBE NEWSWIRE) — Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX, “Alphamin” or the “Company”), a producer of 4% of the world’s mined tin1 from its high grade operation in the Democratic Republic of Congo, is pleased to provide the following operational and financial update for the quarter ended December 2020:

  • Record EBITDA of $16,7m at a tin price of $18,497/t (Current: ~$24,000/t)
  • Record tin production of 2,898 tons, up 13% from the previous quarter
  • Abnormal seasonal rains resulted in logistical constraints which negatively impacted Q4 2020 sales volumes (down 14% from the previous quarter)
  • Q1 2021 tin sales guidance of 3,200 tons (Q4 2020: 2,306 tons) on improved road conditions
  • Commencement of drilling campaign at the adjacent Mpama South deposit
  • Fine tin recovery plant construction 80% complete

Operational and Financial Summary for the Quarter ended December 2020

2

Description Units Actual
    Quarter
ended
December
2020
Quarter
ended
September
2020
Variance
Tons Processed Tons 93 560 96 086 -3 %
Tin Grade Processed % Sn 4,2 3,8 10 %
Overall Plant Recovery % 74 71 4 %
Contained Tin Produced Tons 2 898 2 563 13 %
Contained Tin Sold Tons 2 306 2 695 -14 %
EBITDA US$’000 16 748 16 052 4 %
AISC per ton tin sold US$/t 11 384 10 777 6 %
Tin Price Achieved US$/t 18 497 17 436 6 %

Operational and Financial Performance

Tin production increased 13% to a quarterly record of 2,898 tons and was higher than our previous market guidance of 2,600 to 2,800 tons. This outperformance was due to better than expected tin feed grades and plant recoveries. The processing plant performed at an average recovery of 74% for the quarter, including a record recovery of 77% achieved in December 2020.

Quarterly sales decreased by 14% due to extreme seasonal rains impacting export road conditions. Weather stations across the export route reported rainfall above 159% of the long-term mean.

EBITDA for Q4 2020 increased to a record $16,7million, albeit negatively impacted by lower tin sales volumes. The short dry-season (Jan-March) allows road maintenance to be done and already road conditions have improved. We expect to sell approximately 3,200 tons of contained tin during Q1 2021 thereby recouping most of the past quarter’s sales shortfall.

AISC per ton of tin sold in Q4 2020 increased by 6% to $11,384 from the previous quarter. The increase followed additional outbound road maintenance costs and employee bonus provisions as well as the impact from lower unit production costs resulting in a reduced concentrate stockpile valuation.

The LME tin price has increased from approximately US$18,497/t during Q4 2020 to a current level of ~US$24,000/t, which bodes well for the Company’s 2021 earnings.

The Bisie tin mine recorded zero lost-time injuries during the past quarter.

Alphamin’s audited consolidated financial statements and accompanying Management’s Discussion and Analysis for the quarter and year ended 31 December 2020 are available under the Company’s profile at www.sedar.com.

Production and AISC Guidance for the year ending December 2021

3

Alphamin’s short-term objective is to increase annualised contained tin production from the current level of 11,000t to 13,000t. This increase is expected from July 2021 following the commissioning of the previously announced fine tin recovery plant (“FTP”) and a planned increase of 5% in processed ore volumes.

On this basis, we expect contained tin production of 5,500t in H1 2021 increasing to 6,500t in H2 2021, which would achieve our annualised production goal of 13,000t thereafter.

AISC per ton of tin sold is expected to increase on the back of higher tin prices as royalties and marketing fees escalate. Additionally, sustaining capital expenditure will likely be higher than 2020.

Covid-19 Pandemic and Impact on Operations

The health of our employees is of paramount importance and in this regard the Company has a range of Covid-19 awareness, prevention and other risk mitigation controls in place.

To date, the Company has been able to continue with normal production and concentrate sales activities and has not been negatively affected by the Covid-19 pandemic.

Growth Initiatives

The fine tin recovery plant is 80% complete with full commissioning targeted during June 2021. Estimated expenditure at completion is substantially in line with the budget of US$4.6 million. The fine tin recovery plant has the potential to increase contained tin production by 5%-10% effective July 2021.

Drilling at the Mpama South deposit, located only 750m south of the current processing facility, commenced in December 2020. Drilling has progressed well with 4,152m (20 holes) completed by 28 February 2021. Our objective is to declare a maiden Mineral Resource during 2021 and to test the limits of mineralisation on this deposit to depths of up to 500m below surface and along strike to better understand the potential for establishing another long life, high grade mine at the Bisie complex. The lead time to convert drill holes to final assays is two to three months – assays for the first batch of seven drill holes are expected to be completed during the next week whereafter a market announcement will be made.

While Mpama South could provide an opportunity to increase the production rate and life of operations at Bisie, an extension of the life of mine at Mpama North (the current producing orebody) can be confirmed by drilling down-dip and along strike beyond the northernmost holes drilled in the 2014 drilling campaign. A diamond drilling campaign is planned for 2021 from an underground drilling drive (under development) located on Level 6 at Mpama North.

Further, the 14km long Bisie Ridge, hosting both Mpama North and South, has a plethora of anomalous geochemical targets for follow up and lies entirely within Alphamin’s tenements. In this regard, the Company has identified two drill targets for 2021 (in addition to Mpama North and Mpama South).

Qualified Person

Mr Vaughn Duke Pr.Eng. PMP, MBA, B.Sc. Mining Engineering (Hons.), is a qualified person (QP) as defined in National Instrument 43-101 and has reviewed and approved the scientific and technical information contained in this news release. He is a Principal Consultant, Partner and Director of Sound Mining Solutions, an independent technical consultant to the Company.

FOR MORE INFORMATION, PLEASE CONTACT:

Maritz Smith                                
CEO                        
Alphamin Resources Corp.                        
Tel: +230 269 4166
E-mail: [email protected] 


CAUTION REGARDING FORWARD LOOKING STATEMENTS

Information in this news release that is not a statement of historical fact constitutes forward-looking information. Forward-looking statements contained herein include, without limitation, statements relating to anticipated mining, processing and production and sales volumes, timing and cost of completion of the Company’s fine tin recovery plant and its impact on production, the timing and success of additional exploration drilling, and road conditions for the export of tin produced. Forward-looking statements are based on assumptions management believes to be reasonable at the time such statements are made. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Although Alphamin has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Factors that may cause actual results to differ materially from expected results described in forward-
looking statements include, but are not limited to: uncertainties associated with Alphamin’s resource and reserve estimates, uncertainties regarding estimates of the expected mined tin grades, processing plant performance and recoveries, uncertainties regarding global supply and demand for tin and market and sales prices, uncertainties with respect to social, community and environmental impacts, uninterupted access to required infrastructure, adverse political events, impacts of the global Covid-19 pandemic on mining operations and commodity prices as well as those risk factors set out in the Company’s Management Discussion and Analysis and other disclosure documents available under the Company’s profile at

www.sedar.com

. Forward-looking statements contained herein are made as of the date of this news release and Alphamin disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.


USE OF NON-IFRS FINANCIAL PERFORMANCE MEASURES

This announcement refers to the following non-IFRS financial performance measures: Earnings before interest, taxes, depreciation and amortization (“EBITDA”) and All-In Sustaining Cost (“AISC”).

These measures are not recognized under IFRS as they do not have any standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other issuers. We use these measures internally to evaluate the underlying operating performance of the Company for the reporting periods presented. The use of these measures enables us to assess performance trends and to evaluate the results of the underlying business of the Company. We understand that certain investors, and others who follow the Company’s performance, also assess performance in this way.

We believe that these measures reflect our performance and are useful indicators of our expected performance in future periods. This data is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.


EBITDA

EBITDA provides insight into our overall business performance (a combination of cost management and growth) and is the corresponding flow drivers towards the objective of achieving industry-leading returns. This measure assists readers in understanding the ongoing cash generating potential of the business including liquidity to fund working capital, servicing debt, and funding capital expenditures and investment opportunities. EBITDA is profit before net finance expense, income taxes and depreciation, depletion, and amortization.


Cash Costs

This measures the cash costs to produce a ton of payable tin. This measure includes mine operating production expenses such as mining, processing, administration, indirect charges (including surface maintenance and camp and tailings dam construction costs), smelting costs and deductions, refining and freight, distribution, royalties and product marketing fees. Cash Costs do not include depreciation, depletion, and amortization, reclamation expenses, capital sustaining, borrowing costs and exploration expenses.


AISC

This measures the cash costs to produce a ton of payable tin plus the capital sustaining costs to maintain the mine, processing plant and infrastructure. This measure includes the Cash Cost per ton and capital sustaining costs less concentrate stock movement divided by tons of payable tin sold. All-In Sustaining Cost per ton does not include depreciation, depletion, and amortization, reclamation, borrowing costs and exploration expenses.

Sustaining capital expenditures are defined as those expenditures which do not increase payable mineral production at a mine site and excludes all expenditures at the Company’s projects and certain expenditures at the Company’s operating sites which are deemed expansionary in nature. The following table reconciles sustaining capital expenditures to the Company’s total capital expenditures:

 __________________________________________________________________________________________ 
Data obtained from International Tin Association Tin Industry Review 2020
2
Production information is disclosed on a 100% basis. Alphamin indirectly owns 84.14% of its operating subsidiary to which the information relates.
3Production and sales guidance is based on certain estimates and assumptions, including but not limited to: quantity of material processed, tin grades of processed material and processing recoveries, truck availabilities for tin sales and assumes mining operations will continue to be conducted in the same manner as the previous quarter and will not be further impacted by the Covid-19 pandemic.



OTRK BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Ontrak, Inc. Investors to Secure Counsel Before Important Deadline – OTRK

OTRK BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Ontrak, Inc. Investors to Secure Counsel Before Important Deadline – OTRK

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Ontrak, Inc. (NASDAQ: OTRK) between November 5, 2020 and February 26, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021.

SO WHAT: If you purchased Ontrak securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Ontrak class action, go to http://www.rosenlegal.com/cases-register-2052.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ontrak class action, go to http://www.rosenlegal.com/cases-register-2052.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

Preformed Line Products Announces Results For The Fourth Quarter And Full Year 2020

PR Newswire

MAYFIELD VILLAGE, Ohio, March 5, 2021 /PRNewswire/ — Preformed Line Products Company (NASDAQ:  PLPC) today reported financial results for the fourth quarter and the full year 2020.

Net sales in the fourth quarter of 2020 were $118.5 million compared to $113.6 million in the fourth quarter of 2019.  Net sales for 2020 were $466.4 million compared to $444.9 million in 2019.  This represents an 4% increase for the fourth quarter and a 5% increase for the year.

Net income for the quarter ended December 31, 2020 was $2.7 million, or $0.53 per diluted share, compared to $5.6 million, or $1.09 per diluted share, for the comparable period in 2019. Net income for the year ended December 31, 2020 was $29.8 million, or $5.98 per diluted share, compared to $23.3 million, or $4.58 per diluted share in 2019. 

Rob Ruhlman, Chairman and Chief Executive Officer, said, “The record net sales and earnings per share in 2020, a very unique year, are the result of the commitment and dedication of our global team over several years.  This represents back-to-back record annual net sales and the third consecutive year of record domestic net sales.  While dealing with the added challenges of COVID-19 protocols, our global operations continued to meet growing customer demand.  Net sales increased in all but the Asia-Pacific segment which was more negatively impacted by the COVID-19 pandemic.  Most notably, our PLP-USA operations achieved annual net sales growth of nearly 13%, thanks to the strength and significance of our U.S. based manufacturing facilities which remained fully operational throughout the pandemic.  We anticipate COVID-19 will continue to challenge our business as well as the global economy well into 2021. While disruptive, the pandemic created challenges that were met by our teams which ultimately made us stronger as a company.  As always, we are fully committed to providing our customers with the high-quality products they require, while staying focused on the safety and well-being of our employees, customers, vendors and their families.”

Founded in 1947, Preformed Line Products is an international designer and manufacturer of products and systems employed in the construction and maintenance of overhead and underground networks for energy, communications, and broadband network companies.

Preformed’s world headquarters are in Cleveland, Ohio, and the Company operates two domestic manufacturing centers located in Rogers, Arkansas, and Albemarle, North Carolina.  The Company serves its worldwide market through international operations in Argentina, Australia, Austria, Brazil, Canada, China, Colombia, Czech Republic, England, France, Indonesia, Malaysia, Mexico, New Zealand, Poland, Russia, South Africa, Spain, Thailand and Vietnam.

This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the Company, including those statements regarding the Company’s and management’s beliefs and expectations concerning the Company’s future performance or anticipated financial results, among others. Except for historical information, the matters discussed in this release are forward-looking statements that involve risks and uncertainties which may cause results to differ materially from those set forth in those statements.  Among other things, factors that could cause actual results to differ materially from those expressed in such forward-looking statements include the uncertainty in business conditions and economy due to COVID-19 including the severity and duration of business disruption caused by the pandemic, the strength of the economy and demand for the Company’s products and the mix of products sold, the relative degree of competitive and customer price pressure on the Company’s products, the cost, availability and quality of raw materials required for the manufacture of products, and the Company’s ability to continue to develop proprietary technology and maintain high quality products and customer service to meet or exceed new industry performance standards and individual customer expectations, and other factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the Company’s 2019 Annual Report on Form 10-K filed with the SEC on March 6, 2020 and subsequent filings with the SEC.  The Annual Report on Form 10-K and the Company’s other filings with the SEC can be found on the SEC’s website at http://www.sec.gov.  The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

 


PREFORMED LINE PRODUCTS COMPANY


STATEMENTS OF CONSOLIDATED OPERATIONS


(In thousands, except per share data)

Three Months Ended December 31

Twelve Months Ended December 31

2020

2019

2020

2019

Net sales

$ 118,506

$ 113,649

$ 466,449

$ 444,861

Cost of products sold

81,883

77,469

312,436

304,266


GROSS PROFIT

36,623

36,180

154,013

140,595

Costs and expenses

Selling

9,408

9,741

35,637

36,609

General and administrative

16,432

13,320

56,335

51,806

Research and engineering

4,676

4,378

17,625

17,187

Other operating expense – net

2,239

919

4,209

2,366

32,755

28,358

113,806

107,968


OPERATING INCOME 

3,868

7,822

40,207

32,627

Other income (expense)

Interest income

33

170

259

783

Interest expense

(464)

(529)

(2,396)

(2,217)

Other income – net

726

(40)

2,501

265

295

(399)

364

(1,169)


INCOME BEFORE INCOME TAXES 

4,163

7,423

40,571

31,458

Income taxes

1,505

1,821

10,810

8,122


NET INCOME

$    2,658

$    5,602

$  29,761

$  23,336

Less: Net income attributable to noncontrolling interests

(11)

(22)

(42)

33


NET INCOME ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS

$    2,669

$    5,624

$  29,803

$  23,303


EARNINGS PER SHARE OF COMMON STOCK ATTRIBUTABLE


TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS:

Basic

$      0.54

$      1.12

$      6.05

$      4.63

Diluted

$      0.53

$      1.09

$      5.98

$      4.58

Cash dividends declared per share

$      0.20

$      0.20

$      0.80

$      0.80

Weighted-average number of shares outstanding – basic

4,899

5,005

4,923

5,031

Weighted-average number of shares outstanding – diluted

5,027

5,147

4,984

5,087

 


PREFORMED LINE PRODUCTS COMPANY


CONSOLIDATED BALANCE SHEETS

December 31,

December 31,


(Thousands of dollars, except share and per share data)

2020

2019


ASSETS

Cash and cash equivalents

$        45,175

$        38,929

Accounts receivable, less allowances of $3,464 ($3,849 in 2019)

92,686

83,517

Inventories – net

97,537

95,718

Prepaids

17,660

9,522

Other current assets

3,256

4,289


TOTAL CURRENT ASSETS

256,314

231,975

Property, plant and equipment – net

125,965

124,018

Other intangibles – net

14,443

15,116

Goodwill

29,508

27,840

Deferred income taxes 

10,863

7,564

Other assets

23,994

27,058


TOTAL ASSETS

$      461,087

$      433,571


LIABILITIES AND SHAREHOLDERS’ EQUITY

Trade accounts payable

$        31,646

$        28,282

Notes payable to banks

17,428

8,696

Current portion of long-term debt

5,216

3,354

Accrued compensation and amounts withheld from employees

14,736

11,817

Accrued expenses and other liabilities

34,748

28,924


TOTAL CURRENT LIABILITIES

103,774

81,073

Long-term debt, less current portion

33,333

53,722

Other noncurrent liabilities and deferred income taxes

31,911

30,208


SHAREHOLDERS’ EQUITY

Shareholders’ equity:

Common shares – $2 par value, 15,000,000 shares authorized, 4,902,233 and
4,992,979 issued and outstanding, as of December 31, 2020 and December 31, 2019, respectively

13,028

12,848

Common shares issued to rabbi trust, 265,508 and 267,641 shares at
December 31, 2020 and December 31, 2019, respectively

(10,940)

(10,981)

Deferred Compensation Liability

10,940

10,981

Paid-in capital

43,134

38,854

Retained earnings

379,035

353,292

Treasury shares, at cost, 1,611,927 and 1,431,235 shares at 
December 31, 2020 and December 31, 2019, respectively

(88,568)

(79,106)

Accumulated other comprehensive loss

(54,551)

(57,353)


TOTAL PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS’ EQUITY

292,078

268,535

Noncontrolling interest

(9)

33


TOTAL SHAREHOLDERS’ EQUITY

292,069

268,568


TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$      461,087

$      433,571

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/preformed-line-products-announces-results-for-the-fourth-quarter-and-full-year-2020-301241543.html

SOURCE Preformed Line Products Company

TCDA FILING DEADLINE IN 3 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Tricida Inc.

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Tricida Inc. (“Tricida” or the “Company”) (NASDAQ: TCDA) from September 4, 2019 through October 28, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased Tricida securities, and/or would like to discuss your legal rights and options please visit Tricida Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On July 15, 2020, Tricida issued a press release announcing that, on July 14, 2020, the Company received a notification from the FDA, stating that as part of the FDA’s ongoing review of the Company’s NDA for veverimer, “the FDA has identified deficiencies that preclude discussion of labeling and postmarketing requirements/commitments at this time.” Tricida stated that “[t]he notification does not specify the deficiencies identified by the FDA.” On this news, Tricida’s stock price fell $10.56 per share, or 40.31%, to close at $15.64 per share on July 16, 2020.

Then, on October 29, 2020, Tricida announced an update on its End-of-Review Type A meeting with the FDA regarding the veverimer NDA, advising investors that the Company “now believes the FDA will also require evidence of veverimer’s effect on CKD progression from a near-term interim analysis of the VALOR-CKD trial for approval under the Accelerated Approval Program and that the FDA is unlikely to rely solely on serum bicarbonate data for determination of efficacy.” Concurrently, Tricida disclosed that it “is significantly reducing its headcount from 152 to 59 people and will discuss its commitments with vendors and contract service providers to potentially provide additional financial flexibility.” On this news, Tricida’s stock price fell $3.90 per share, or 47.16%, to close at $4.37 per share on October 29, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than March 8, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member..

If you purchased Tricida securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/tricidainc-tcda-shareholder-class-action-lawsuit-stock-fraud-353/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]